Safety of B-blockers in Patients with Chronic Hepatitis C under Treatment with sofosbuvir and Daclatasvir
(2021). Safety of B-blockers in Patients with Chronic Hepatitis C under Treatment with sofosbuvir and Daclatasvir. EKB Journal Management System, 1(1), 58-68. doi: 10.21608/aumj.2021.227984
. "Safety of B-blockers in Patients with Chronic Hepatitis C under Treatment with sofosbuvir and Daclatasvir". EKB Journal Management System, 1, 1, 2021, 58-68. doi: 10.21608/aumj.2021.227984
(2021). 'Safety of B-blockers in Patients with Chronic Hepatitis C under Treatment with sofosbuvir and Daclatasvir', EKB Journal Management System, 1(1), pp. 58-68. doi: 10.21608/aumj.2021.227984
Safety of B-blockers in Patients with Chronic Hepatitis C under Treatment with sofosbuvir and Daclatasvir. EKB Journal Management System, 2021; 1(1): 58-68. doi: 10.21608/aumj.2021.227984

Safety of B-blockers in Patients with Chronic Hepatitis C under Treatment with sofosbuvir and Daclatasvir

Aswan University Medical Journal
Volume 1, Issue 1, June 2021, Page 58-68  XML PDF (572.51 K)
Document Type: Original Article
DOI: 10.21608/aumj.2021.227984
View on SCiNiTO View on SCiNiTO
Statistics
Article View: 173
PDF Download: 877